Advertisements



Dynavax reports interim data for study of SD-101 in combination Merck"s Keytruda

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Dynavax reports data for Phase 1b/2 trial of SD-101 in combination with Keytruda

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update

Initial data from ongoing open label study of pepinemab (VX15/2503) in combination with avelumab in non-small cell lung cancer expected in 2Q 2019 Enroll.....»»

Category: earningsSource: benzingaMar 13th, 2019

Merck Gets Priority Review for Yet Another Keytruda sBLA

Merck's (MRK) sBLA to include overall survival data from a key lung cancer study on Keytruda's label gets .....»»

Category: smallbizSource: nytSep 13th, 2018

Bluebird Bio reports interim data from Phase 1 HGB-206 study of LentiGlobin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Epizyme reports updated interim data from Phase 2 study of tazemetostat

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Merck"s Keytruda shows promise for melanoma

Merck said long-term data from its cancer drug Keytruda showed promise in treating advanced melanoma patients. Fred Katayama reports......»»

Category: videoSource: reutersJun 4th, 2018

Dynavax to present new SD-101 in combination with Keytruda data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

A combination of Merck's Keytruda and chemotherapy cut lung cancer death rates in half. New study results released Monday continue to cemen.....»»

Category: europeSource: fortuneApr 16th, 2018

Merck"s Keytruda combination in NSCLC approved by European Commission

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 14th, 2019

Concert Pharmaceuticals reports interim CTP-543 Phase 2 data in alopecia areata

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 1st, 2019

Axonics reports "positive" top-line data from ARTISAN-SNM pivotal study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2019

Merck: FDA grants priority review to sBLA for KEYTRUDA/Inlyta combination

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 15th, 2019

Hemispherx reports start of clinical trial combining Ampligen, Merck"s Keytruda

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Merck: CHMP adopts positive opinion for KEYTRUDA combination

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 4th, 2019

Merck reports Q4 Keytruda sales up 66% y/y to $2.15B

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 1st, 2019

Amgen/Allergan"s Rituxan Biosimilar Meets Goal in Phase III

Amgen (AMGN) along with partner Allergan reports upbeat top-line data from a phase I/III study on ABP 798.....»»

Category: dealsSource: nytJan 25th, 2019

Sorrento Therapeutics announces interim RTX study data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Vertex"s (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint

Vertex (VRTX) reports positive phase II data of its pipeline candidate VX-150 in patients with pain caused by small fiber neuropathy. .....»»

Category: personnelSource: nytDec 19th, 2018

Achillion Reports Positive Interim Data on Factor D Inhibitors

Zacks.....»»

Category: topSource: redinewsDec 18th, 2018

Achillion reports positive interim data for ACH-4471 Phase 2 trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018